help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arimura, A.
Right arrow Articles by Schally, A. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arimura, A.
Right arrow Articles by Schally, A. V.

Endocrinology, Vol 98, 540-543, Copyright © 1976 by Endocrine Society


ARTICLES

Blockade of the stress-induced decrease in blood GH by anti- somatostatin serum in rats

A Arimura, WD Smith and AV Schally

To investigate the physiological role of somatostatin in the GH release mechanism, the effect of passive immunization with somatostatin on basal and poststress serum GH levels was examined in rats. Sheep antiserum to somatostatin or normal sheep serum (NSS) was injected iv into adult male rats 5 days, 3 days and 1 day before applying stressful stimuli. Thirty min after the first bleeding under ether, the mean serum GH level increased from 36.3 to 76.1 ng/ml in the antiserum- treated rats and decreased from 63.7 to 16.8 ng/ml in the NSS-treated rats, but the difference for either group was not significant due to the large variation. In another experiment, electroshock was applied to conscious rats. The mean poststress GH level in the rats pre-treated 3 h previously with the antiserum was 34.4 ng/ml, a value significantly higher than the GH level in the rats pretreated with NSS (0.9 ng/ml) or in non-treated rats (0.5 ng/ml). It was concluded that the stress- induced decrease of GH secretion in rats is at least partly due to an increased release of hypothalamic somatostatin and/or immunologically related GH release-inhibiting hormone(s). Persistent variation in serum GH levels after neutralization of endogenous somatostatin by the antiserum suggests that another regulator, probably GH releasing hormone, also plays a role in controlling GH secretion.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1976 by The Endocrine Society